Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.70794 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.65062 | 61 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.64857 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.54225 | 60 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.57562 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.89462 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.71778 | 61 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.63739 | 61 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.63781 | 61 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.64623 | 61 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.63914 | 61 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.58422 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.65538 | 61 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.6414 | 61 |